Artax Biopharma Secures $8 Million Financing for Autoimmune Disease Treatment

Artax Biopharma revolutionizes autoimmune disease treatment with $8 million funding round and potential for recalibrating T-cell receptor responses in a Phase 2a clinical trial for psoriasis.